Table 3.
Biomaterial | Bioink formulation | Concentration | Printing approach | Technique | Cell type | Crosslinking | Printed structures | Capillary formation? | ref |
---|---|---|---|---|---|---|---|---|---|
Agarose | Agarose | 2–8% wt. | Indirect | EBB | Perfused with HUVEC suspension | Physical | Microchannels in GelMA matrix | No | 517 |
Agarose and collagen | Agarose: 0.5% wt. Collagen: 0.5% wt. |
Direct | DBB | HUVECs and HDFs | Physical | Hydrogel column | Yes | 450 | |
Alginate | Alginate | 0.8% wt. | Indirect | DBB | n/a | Physical | Bifurcation model with 90 μm channel | Yes | 376 |
Alginate | 1.5% wt. | Direct | EBB | Rat heart endothelial cells | Physical | 3D lattice construct with viable ECs | No | 464 | |
Alginate | 1–3% wt. | Indirect | Embedded 3D bioprinting | Perfused with HUVEC suspension | Physical | Patterned vascular networks in agarose/gelatin and GelMA hydrogels | No | 467 | |
Alginate + CaCl2 + platelet-rich plasma | Alginate: 1% w/v CaCl2: 0.025% w/v Plasma: 50 U |
Direct | EBB | HUVECs | Physical | Branching vascular structure | No | 470 | |
Carbohydrate glass | Sugar glass maintained at 165 °C | 25 g glucose + 53 g sucrose + 10 g dextran in 50 mL water | Combined | EBB | Perfused with HUVEC suspension | Physical | Patterned vascular networks in multiple hydrogel matrices | Yes | 242 |
Sugar glass maintained at 155 °C | 100 g isomalt + 10 g dextran in 60 mL water | Indirect | EBB | Perfused with HUVEC suspension | Physical | Patterned vascular networks in a fibrin hydrogel | Yes | 478 | |
Sugar glass | n/a | Indirect | EBB | n/a | Physical | Patterned vascular networks in a PDMS hydrogel | Yes | 479 | |
Sugar glass + CaCl2 maintained at 110 °C | 3% w/v | Indirect | EBB | n/a | Physical | Patterned vascular networks in an alginate hydrogel | No | 480 | |
Hyaluronic acid (HA) | Ad-HA and CD- HA | Ad-HA: 4% wt. CD-HA: 4% wt. |
Indirect | Embedded 3D bioprinting | Perfused with HUVEC suspension | Chemical and physical | Endothelialized microchannels in cell-degradable HA support hydrogels | Yes | 244 |
GMHA/GelMA | GMHA: 2% w/v GelMA: 5% w/v |
Direct | LAB | HUVECs and ADSCs | Chemical | Vascularized hepatic model | Yes | 503 | |
HA/GelMA | HA: 1% w/v GelMA: 2.5% w/v |
Direct | LAB | HUVECs and 10T1/2 cells | Chemical | Prevascularized tissue constructs with complex 3D microarchitecture | Yes | 504 |
n/a = not applicable.
HDF = human dermal fibroblast; Ad = adamantane; CD = cyclodextrin; GMHA = glycidyl methacrylate-HA